Eli Lilly and Co shared updated results of Inluriyo (imlunestrant) from a Phase 3 study in previously treated breast cancer patients.

Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive ...

Leading efforts to translate research into treatments at the NIH had felt, for physician Josh Fessel, like the way he could ...

Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) researchers, identified ...

Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) researchers, identified key factors that drive tumor evolution and ...

Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of ...

Five institutions conducting pediatric cancer research will get $5 million in state funds to help with their work.

The National Institutes of Health awarded 22% fewer grants this year under the Trump administration than the 2015-2024 per ...

An effort to make NIH-funded research immediately accessible to the public has led to disruption and financial strain for ...

Research Recovery Program is Designed to Sustain Laboratories and Preserve High-Quality, High-Potential NIH or DoD ...

Together, the N.I.H. and the N.S.F. had a nearly $60 billion annual budget for funding future breakthroughs in science and ...

NewsNation anchor Chris Cuomo joins Rising to discuss his new special "Killing Cancer: The Power Within," which airs Tuesday at 10 pm on NewsNation.